Royal Bank of Canada
SER icon

Royal Bank of Canada’s Serina Therapeutics SER Stock Holding History

Royal Bank of Canada’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 7950
2022
Q2 		$0 Hold
1
– – ﹤0.01% 7781
2022
Q1 		$0 Hold
1
– – ﹤0.01% 8082
2021
Q4 		$0 Hold
1
– – ﹤0.01% 7944
2021
Q3 		$0 Sell
1
-3
-75% -$126 ﹤0.01% 7917
2021
Q2 		$0 Sell
4
-10
-71% -$502 ﹤0.01% 7731
2021
Q1 		$1K Sell
14
-3
-18% -$210 ﹤0.01% 7331
2020
Q4 		$1K Hold
17
– – ﹤0.01% 6980
2020
Q3 		$0 Sell
17
-24
-59% -$856 ﹤0.01% 6980
2020
Q2 		$1K Sell
41
-22
-35% -$648 ﹤0.01% 6496
2020
Q1 		$2K Buy
63
+61
+3,050% +$2.87K ﹤0.01% 6345
2019
Q4 		$0 Sell
2
-20
-91% -$1.08K ﹤0.01% 7179
2019
Q3 		$1K Buy
22
+6
+38% +$569 ﹤0.01% 6531
2019
Q2 		$2K Buy
16
+4
+33% +$542 ﹤0.01% 6611
2019
Q1 		$2K Sell
12
-1
-8% -$146 ﹤0.01% 6556
2018
Q4 		$1K Buy
+13
New +$1.65K ﹤0.01% 6625

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada's SER Position: Q3 2022 in Review

Royal Bank of Canada sold out of Serina Therapeutics (SER) in Q3 2022, closing a stake of 1 share.

Royal Bank of Canada first reported a position in SER in Q4 2018 and held it in 15 quarters. The position peaked at $2K in Q1 2020. 31 funds tracked by Wall St. Rank hold SER as of Q3 2022.

  • Royal Bank of Canada reported no remaining Serina Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Serina Therapeutics share in Q3 2022.
  • Royal Bank of Canada first reported a position in Serina Therapeutics in Q4 2018 and held it in 15 quarters.
  • Royal Bank of Canada's Serina Therapeutics position peaked at $2K in Q1 2020.
  • 31 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2022.

Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.